Major basic protein (MBP), the core of the eosinophil granule, is a potent toxin for parasites and mammalian cells; it also causes histamine release from mast cells and basophils. Plasma levels of MBP are increased in all pregnant women, and MBP has been localized by immunofluorescence to placental X cells and placental-site giant cells. Analyses of plasma MBP levels during pregnancy showed a striking cor. relation between increases late in the third trimester and spontaneous onset of labor. In one case with premature labor, the plasma MBP level also was increased coincidentally with labor. In contrast, in cases of prolonged gestation in which labor was induced, there were no late increases in MBP levels. Also, uterine contraction during spontaneous labor or oxytocin-induced labor did not cause elevations of plasma MBP. Measurement of plasma MBP levels in pregnancy may be useful for the prediction of labor and for the development of new means of intervention for premature labor and prolonged gestation.
The eosinophil major basic protein (MBP) forms the core of the eosinophil granule and accounts for a major portion ofthe granule protein (1) (2) (3) (4) (5) . MBP is toxic to parasites and mammalian cells in vitro (6) (7) (8) (9) (10) , and it is deposited on degenerating parasites in vivo (11) . It damages respiratory epithelium in vitro (8) , and evidence exists that it is a mediator of inflammation in asthma (12) . MBP also causes noncytotoxic histamine release from mast cells and basophils (13, 14) , interacts with coagulation factors (2) , and indirectly alters smooth muscle contractility (15) .
During investigations of hypersensitivity diseases in pregnancy, increased plasma levels of eosinophil MBP were found in all pregnant women (16, 17) . Because eosinophilia does not normally accompany human pregnancy and because serum levels of other eosinophil proteins are not increased in pregnancy, a source other than the eosinophil was sought for this pregnancy-associated MBP. Immunofluorescence studies showed that MBP is localized to the poorly defined placental trophoblasts called X cells (17) . Pregnancy-associated MBP has been purified from human placenta; it is a strongly basic protein (pI > 11) with a molecular weight of 14,000 and is biochemically indistinguishable from eosinophil granule MBP (unpublished data). This physicochemical identity with eosinophil MBP implies that pregnancy-associated MBP has comparable potent biologic functions.
In a study of the biologic role of MBP in human pregnancy, we have measured the MBP concentration in maternal plasma during gestation. This study reveals a striking correlation between increases ofplasma MBP level late in the third trimester and onset of labor.
MATERIALS AND METHODS
Plasma Samples. Twenty-one women with uncomplicated pregnancies participated in this study; all blood samples were obtained following informed consent. The patients' histories were reviewed after delivery to determine age, parity, length of gestation, sex and weight of fetus, and course of labor and delivery. Length of gestation was calculated from date of last menses, ultrasonographic analysis of fetal biparietal diameter, and basal temperature charts. Venous blood samples (2 ml) were drawn into EDTA anticoagulant and centrifuged; the plasma samples were stored at -20TC. For 16 women, blood samples were obtained at weekly intervals from 32 weeks of gestation through 6 weeks postpartum. One sample was obtained at admission to the labor suite. For one woman, blood samples were obtained at weekly intervals throughout the pregnancy and every third day during the last 2 weeks before labor. Blood samples were obtained from four other women at intervals throughout labor (labor induced with oxytocin in two and spontaneous in two).
Radioimmunoassay for MBP. Plasma samples were reduced and alkylated as described (18) Nonspecific binding was measured on PPF-E-treated sticks incubated with 125I-labeled MBP. Internal standards consisted of plasma samples from a normal man and from a patient with hypereosinophilic syndrome. All plasma samples from a subject were analyzed in a single assay to minimize interassay variation. The intraassay and interassay coefficients of variation were 7.9% and 7.2%, respectively. MBP values were consistent with those obtained in another radioimmunoassay using polyclonal rabbit antiserum (18 
RESULTS
MBP levels were increased by 4 weeks after conception and showed a steady increase until approximately 20 weeks of gestation ( Fig. 1) . Between' 20 and 33 weeks, the MBP level remained constant (varying less than 13% from the mean).
This was followed by a late increase, with the greatest increase during the last week before spontaneous parturition. The late increase in MBP accounted for 54% of the total increase. MBP levels fell rapidly after parturition.
In 13 of 16 additional pregnant women, radioimmunoassay ofblood drawn at weekly intervals from 32 weeks ofgestation to 6 weeks postpartum revealed a late increase in MBP; all 13 went into labor spontaneously. In Fig. 2 , illustrating the plasma MBP concentrations in three of these women, a temporal association between the late increase in MBP and the onset oflabor is evident. In women delivering at 38 weeks (e~g., Fig. 2 Top), increases in MBP were evident at 35 ± 0.6 weeks (mean ± SD, n = 4), whereas in women delivering at 41 weeks (e.g., Fig. 2 Middle), MBP concentrations did not change before 38 ± 0 weeks (n = 4). The onset of premature labor in one woman at 34 weeks was associated with a 35% increase in plasma MBP ( Fig. 2 Bottom) ; labor was arrested by using tocolytic agents, and she subsequently delivered at 40 weeks gestation, after an even greater increase in plasma MBP. The mean postpartum half-life of MBP in these 17 women, calculated by regression analysis (16) , was 12.5 ± 1.9 days (range, 10.1-16.1 days).
Three women in the study failed to begin labor spontaneously, and labor was induced with oxytocin at 42 weeks of gestation; none, of these women exhibited a late increase in MBP (Fig. 3) .
To determine whether increases in plasma MBP in women beginning labor spontaneously might be due to uterine contractions dislodging or "squeezing out" MBP, we studied plasma levels of another placental protein, hPL, which is similar in size to MBP and has also been localized to X cells (20, 21) . hPL leyels did not change in the same plasma samples displaying dramatic MBP increases (Fig. 2) blood samples from women beginning labor spontaneously showed hPL concentration changes similar to those in women in whom labor was induced (Figs. 2 and 3) . Also, plasma MBP levels did not change significantly during labor, whether induced or spontaneous (Table 1) . Thus, neither plasma MBP nor hPL concentration changes are related to uterine contractions. Fig. 4 summarizes the changes in plasma mean MBP levels for the 16 women. In women whose onset of labor was spontaneous, the increase in MBP concentration during the final weeks ofgestation was 42 + 6.6% ofthe mean peak MBP level of 5720 ± 2257 ng/ml (± SD). Expressed as a percentage of our best estimate of the level before the increase-i.e., from week 20 to week 33 (see Fig. 1 )-plasma MBP increased a mean of 80 ± 34% (range, 42-172%) in women having The absence of spontaneous labor is correlated with absence of the increase in plasma MBP concentration late in gestation. hPL levels were comparable to those in women with spontaneous labor (Fig. 2) . spontaneous labor. In contrast, women who failed to begin labor spontaneously had little or no change in MBP concentrations (<10%, within the variability of the assay) and the peak MBP level averaged 3529 ± 1533 ng/ml. Therefore, a change in MBP concentration late in pregnancy, rather than the attainment of an absolute value, is associated with the onset of labor.
We used regression analysis to determine whether the peak MBP concentration was related to specific maternal or fetal variables. No significant correlation was seen with maternal age or parity, fetal sex, fetal weight, placental weight, or duration of labor. DISCUSSION Eosinophils cyclically infiltrate the rodent uterus coincidentally with the estrous cycle in response to changes in estrogen levels (22) (23) (24) . The estrogen-induced uterine eosinophilia is associated with marked uterine edema, and various agents that limit uterine eosinophilia also prevent the formation of uterine edema (reviewed in ref. 25) . Eosinophils also accumulate at implantation sites in rhesus monkeys (26) . Still, the function of the eosinophil in reproduction is obscure. The observation that plasma MBP levels are increased in pregnant women directed attention to the possibility that the MBP was derived from eosinophils in the uterus or placenta. However, the virtual absence of eosinophils from the placenta and pregnant uterus, the failure to demonstrate increases in other eosinophil-associated proteins in the plasma of pregnant women, and, most important, the localization of MBP by immunofluorescence to placental septal cysts, X cells, and giant cells suggest that MBP is derived from the placenta (16, 17) . Pregnancy-associated MBP and eosinophil granule MBP are indistinguishable immunochemically and biochemically; they have identical apparent molecular weights, isoelectric points, and peptide maps (unpublished data).
Three lines of evidence show that the late increases in plasma MBP levels are associated with the occurrence of labor. First, in all women whose labor began spontaneously, there was a late increase in plasma MBP prior to the onset of labor (Figs. 1, 2, and 4) . Second, the late increase in MBP consistently occurred 2-3 weeks before the onset of labor [for example, in women beginning labor before 40 weeks of gestation, plasma MBP increased at about weeks 34-36, whereas in women beginning labor after 40 weeks, the increase occurred at about weeks 37-39 ( Fig. 2) ]. Third, and most important, women whose labor did not begin spontaneously did not have a late increase in plasma MBP (Fig. 3) . The possibility that the increase in plasma MBP is due to uterine contractility appears to be excluded by the failure to find plasma MBP increases during oxytocin-induced labor. Thus, the late increase in plasma MBP appears to represent active secretion of MBP rather than displacement of it from the uterine/placental interface by mechanical forces.
The localization of MBP to fetally derived X cells and placental-site giant cells suggests a source for the pregnancy- (20, 21, 27, 28) , their location at the fetomaternal junction, where they form anchoring villi and septa and interdigitate between decidual and myometrial cells, places them in a critical location for the performance of important biologic functions. The finding that an increase in MBP level signals the onset of labor suggests that X cells and placental-site giant cells containing MBP may function in the induction of labor. The idea that X cells in intimate contact with uterine tissue are involved in human labor is not new. In 1964, Dallenbach-Hellweg and Nette (29) described protein inclusions in basal plate trophoblasts (X cells) of mature placentas shortly before parturition but not in specimens obtained after spontaneous delivery, and they suggested that the inclusions were discharged during labor. They also found that these inclusions were membrane-bound, were highly acidophilic, contained protein but not carbohydrate, and often were situated in the perinuclear region. These findings are of interest because immunofluorescence studies ofX cells often show a perinuclear speckling pattern for MBP (17) . Furthermore, pregnancy-associated MBP is highly acidophilic (pI > 11) and unglycosylated (unpublished data) and its eosinophil counterpart is packaged in a membrane-bound granule, presumably to protect the cell from its cytotoxic effects (6) (7) (8) .
The series of biochemical events that culminate in human labor are obscure. Alterations in cortisol (fetal), estrogen, and progesterone concentrations are important to parturition in animals (30, 31) but have been difficult to document in humans (32) (33) (34) (35) . Although the ability of prostaglandins to promote uterine contractions and cervical ripening is clear (35) (36) (37) (38) (39) , the factors that induce prostaglandin production at term are unknown. Similarly, the contractile effects of oxytocin are unmistakably important, but the factors that mediate increased oxytocin responsiveness, by increasing receptor numbers at term, are obscure (40) . Thus, a biologically potent molecule such as MBP could be implicated in the complex interactions that result in labor. The presence of MBP in X cells and placental-site giant cells in direct contact with myometrial cells certainly is appropriate for modulating uterine contractility. Furthermore, eosinophil MBP indirectly alters tracheal smooth muscle contractility (15) , and thus pregnancy-associated MBP could exert similar effects on myometrial smooth muscle.
The association between the late increase in plasma MBP level and labor suggests a means to predict the onset of labor. This would be valuable in deciding whether or not oxytocin induction of myometrial contraction is required for treatment of prolonged pregnancy, in view of the complications of such induction (41) . But perhaps of greater importance is the possibility of predicting, and being able to prevent, premature labor. The patient represented in Fig. 2C had an episode ofpremature labor that was associated with a 35% increase in plasma MBP level. Premature labor is a major cause of low birth weight and thus is one of the leading causes of infant mortality (42 
